Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: In vitro and in vivo studies

Diabetes

Volumn 46, Issue 1, 1997, Pages 81-86

  Desideri, Giovambattista ^a   Ferri, Claudio ^a   Bellini, Cesare ^c   De Mattia, Giancarlo ^a   Santucci, Anna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HYPERTENSION; INSULIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0031024368     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.1.81     Document Type: Article

References (31)

1. Ferri C, Piccoli A, Properzi G, Bellini C, Pittoni V, Valesini G, Santucci A: Insulin stimulates endothelin-1 secretion in vitro and modulates its circulating levels in vivo. J Clin Endocrinol Metab 80:829-835, 1995
2. Hu R, Levin ER, Pedram A, Frank HJL: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 42:351-358, 1993
3. Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, De Mattia G: Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 44:431-436, 1995
4. Takahashi K, Gathei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33:306-310, 1990
5. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin level in patients with essential hypertension (Letter). N Engl J Med 322:205, 1990
6. Ferri C, Laurenti O, Bellini C, Cassone Faldetta M, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels in lean non insulin-dependent diabetic patients: influence of ACE-inhibition. Am J Hypertens 8:40-46, 1995
7. Erdös EG: Angiotensin I converting enzyme. Fed Proc 36:1760-1765, 1977
8. Campbell DJ: Circulating and tissue angiotensin systems. J Clin Invest 79:1-6, 1987
9. Caldwell PRB, Seegal BC, Hsu KC, Das M, Soffer RL: Angiotensin converting enzyme: vascular endothelial localization. Science 191:1050-1051, 1976
10. Ryan JW, Ryan ES, Schultz DR, Whitaker C, Chung A: Subcellular localization of pulmonary angiotensin-converting enzyme (kininase II). Biochem J 146:497-499, 1975
11. Waeber B, Nüssbeiger J, Brunner H: Angiotensin converting enzyme inhbitors in hypertension. In Hypertension, Pathophysiology, Diagnosis and Management. Laragh JH, Brenner BM, Eds. New York, Raven Press, 1990, p. 2209-2232
12. Donnelly R: Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure. J Cardiovasc Pharmacol 20 (Suppl. 11):S38-S44, 1992
13. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura N, Miyata T, Yano T, Shichiri M: Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37:300-307, 1994
14. Clozel M: Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension. Hypertension 18 (Suppl. II):II-37-II-42, 1991
15. Clozel M, Kuhn H, Hefti F: Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16:530-540, 1990
16. Mombouli JV, Iliano S, Nagao T, Scott-Burden T, Vanhoutte PM: Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endotheliumderived relaxing and hyperpolarizing factors. Circ Res 71:137-144, 1992
17. Momose N, Fukuo K, Morimoto S, Ogihara T: Captopril inhibits endothelin secretion from endothelial cells through bradykinin. Hypertension 21:921-924, 1993
18. Yoshida H, Nakamura M: Inhibition by angiotensin converting enzyme inhibitors of endothelin secretion from cultured human endothelial cells. Life Sci 50:PL195-PL200, 1992
19. Bakris GL, Bhandaru S, Akerstrom V, Re RN: ACE-inhibitor-mediated attenuation of mesangial cell growth: a role for endothelin. Am J Hypertens 7:583-590, 1994
20. Wagner OF, Christ G, Wojita JJ, Vierhapper H, Parzer S, Novotny PG, Schneider P, Waldhäusl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267:16066-16068, 1992
21. Jaffe EA, Nachman RL, Becker CG, Mimick CR: Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria J Clin Invest 52:2745-2756, 1973
22. Wiemer G, Schölkens BA, Becker RHA, Busse R: Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endotheliumderived bradykinin. Hypertension 18:558-563, 1991
23. Gräfe M, Bossaller C, Graf K, Auch-Schwelk W, Baumgarten CR, Hildebrandt A, Fleck E: Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol 264:H1493-H1497, 1993
24. Mombouli JV, Vanhoutte PM: Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharmacol 18:926-927, 1991
25. Mineo C, Yagyu Y, Imanaka T, Takano T: Transcellular transport of angiotensin n through a cultured arterial endothelial monolayer. Exp Cell Res 190:99-103, 1990
26. Pohl U, Busse R: Differential vascular sensitivity to luminally and avventitial applied endothelin-1. J Cardiovasc Pharmacol 13 (Suppl. 5):188-190, 1989
27. Ferri C, Bellini C, Desideri G, De Mattia G, Santucci A: Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care 19:1-4, 1996
28. Torlone E, Rambotti AM, Perriello G, Botta G, Santeusanio F, Brunetti P, Bolli GB: ACE-inhibition increased hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 34:119-125, 1991
29. Bobik A, Grooms A, Mitchell A, Grinpukel S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 258:C408-C415, 1990
30. Kahaleh MB: Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: enhanced production and profibrotic action. Arthr Rheum 34:978-983, 1989
31. Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G: Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 17:448-454, 1987